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Determination  of the number  of cells from  which  a  neoplasm  arises can  provide 
clues to its mode of origin. For example, if a  tumor arises as the result of a  rare event 
such  as a  somatic mutation,  unicellular (clonal) origin is anticipated.  In contrast,  a 
multicellular origin  might  be  found  for  a  neoplasm  that  develops  from  a  field  of 
altered  cells.  This  question  can  be  investigated  in  organisms  with  two  or  more 
genetically distinct types of cells. Most such studies have been done in humans using 
as a  marker immunoglobulin or glucose-6-phosphate dehydrogenase in females with 
X-chromosome  inactivation  mosaicism  (1).  The  data  suggest  that  the  majority of 
human  neoplasms  are clonal in origin  at  the  time of study.  Interpretation of these 
indirect investigations of tumorigenesis in man could be facilitated by direct studies 
of tumor  development  in  animals.  Such  studies  have  been  hampered  by  lack  of 
suitable  X-linked  markers,  but  recently  Nielsen  and  Chapman  (2)  described  an 
electrophoretic variant for the X-linked enzyme phosphoglycerate kinase (PGK-1) in 
feral mice. 
Because only one of the two X-chromosomes is active in XX somatic cells, a  female 
mouse  heterozygous  at  the  X-linked  PGK  locus  for  the  usual  Pgk-1 b  gene  and  the 
variant  Pgk-1 a  has  two  populations of cells. In  the cells of one  popuation,  Pgk-1 b is 
active, with consequent production of type B  isoenzyme, whereas in cells of the other 
population,  Pgk-1 a  is  active  and  type  A  isoenzyme  is  synthesized.  Tumors  with  a 
clonal origin in Pgk- 1 b/Pgk- 1  a mice should therefore display B or A-type PGK, whereas 
those with a  multicellular origin may exhibit both B  and A  isoenzymes. We utilized 
this isoenzyme system as a marker to study tumors induced by the chemical carcinogen 
3-methylcholanthrene (MCA). 
Materials  and  Methods 
Animals.  Male  feral  mice with  the  PGK variant  (PGK  type  1 A)  originally trapped in 
Denmark (2), were kindly given to us by Dr. Vernon M. Chapman, Roswell Park Memorial 
Institute, Buffalo, N. Y. We bred these animals with females from inbred strains homozygous 
for the usual Pgk-1 b and used the F1 hybrids heterozygous for the wild type and variant PGK 
genes (Pgk-lb/Pgk-l% The Fa mice were maintained on a standard diet and were injected with 
carcinogen when they weighed m 20-25 g (between 8 and  12 wk of age). 
* Supported by the Medical Research Service of the Veterans Administration. 
Abbreviations used in this paper: DEMLTc, Dulbecco's modified Eagle's medium  supplemented  with  15% 
fetal calf serum,  100 U of penicillin and streptomycin  per liter, and 25 mM Hepes; MCA, 3-methylchol- 
anthrene;  PGK, phosphoglycerate kinase. 
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Induction of Tumors.  Mice were shaved and injected subcutaneously with a  single dose  of 
MCA (Sigma Chemical Co., St. Louis, Mo.) dissolved completely in 0.2 ml olive oil by heating 
in boiling water. Four mice were injected with 0.2 mg MCA and five were injected with 2.0 mg. 
The  animals were  examined twice  weekly  for  palpable tumors  or  other  manifestations of 
malignancy. They were killed and underwent complete autopsy after progressively growing 
tumors were identified. 
Dissection of Tumors.  Each tumor was dissected free of connective tissue and divided into at 
least two to five sections depending upon its nodular architecture. In most neoplasms, each 
nodular section  was  subdivided into small  fragments measuring ~-  3-  to  5-mm  diameter. 
Subsequently,  each such fragment was divided into three equal portions. The two outer portions 
were used for PGK analysis and the center piece was utilized for histologic examination and for 
the establishment of tissue cultures. Blood, parenchymal organs, and muscle fragments adjacent 
to the tumors were also tested for PGK. 
PGK Assay.  PGK phenotypes were determined with a  slight modification of the method 
described by Chen et al. (3). Gels were stained (4) and the activity of the PGK isoenzymes was 
quantitated visually using known mixtures as standards. We found that a minor population in 
a  mixture of cells can be detected with this method if it contributes 2-5% of the total PGK 
activity. 
Tissue Culture.  Tissues were finely minced and placed in Falcon flasks containing  Dulbecco's 
modified Eagle's medium supplemented with  15% fetal calf serum,  100 U  of penicillin and 
streptomycin per  liter,  and  25  mM  Hepes  (DEM-Tc).  Cells  in the  primary cultures were 
analyzed for PGK and cells in the second passage, for chromosomes. 
Cloning of Tumor Cells in Culture.  A single cell suspension of tumor cells was obtained from 
cell cultures by dissociation with 0.25% trypsin. The cells were washed twice in Hank's balanced 
salt solution and adjusted to a concentration of 8-10 cells per milliliter in DEM-Tc. 0.1 ml of 
this suspension was dispensed into each well of Microtest-II plates (Falcon Labware, Div. of 
Becton, Dickinson, & Co., Oxnard, Calif.). The plates were incubated at 37°C for 12 h in a 5% 
CO2,  100% humidity atmosphere. Wells appearing to contain one cell were selected and 0. l ml 
more of DEM-Tc was added. After a colony appeared, the cells were transferred to a 25-cm  2 
flask for clonal amplification and then tested for PGK. 
Histopathology.  Tissues were fixed in 10% formalin in phosphate-buffered salt solution. The 
sections were stained with hematoxylin and eosin. Estimates were made of the percent of tumor 
cells and of nontumor cell admixture without knowledge of the isoenzyme results (5). 
Chromosomal Studies.  0.02 ml of colchicine was added to the tissue culture and after 2 h the 
cells were removed from the flask with trypsin and treated with hypotonic KCI (0.05 M) for 15 
min at room temperature. After fixation in acetic acid:methanol (1:3), the cells were stained 
with Giemsa. For each culture, 50 randomly selected metaphases were scored at  1,000 ×. 
Results 
PGK Phenotypes  in Normal  Tissues.  Each  of 140 specimens of solid tissue from six 
heterozygous  mice exhibited both  B  and A  PGK types  (Table I).  Generally, there 
were equal amounts of B and A isoenzyme activities. 
MCA-induced Tumors.  Two of four Fls (feral mice ×  BALB/c) injected with 0.2 mg 
MCA, and three of five Fas injected with 2.0 mg MCA developed palpable tumors. 
The neoplasms were noted at  the sites of injection after latent periods of 19-25 wk 
and had gross and histologic features typical of fibrosarcomas with anaplastic spindle- 
shaped cells and numerous mitoses (Figs.  1 and 2). Large fibroblast-like cells grew in 
culture from  the primary tumor explants, formed colonies within a  few  days, and, 
muhilayers within 2-3 wk  (Figs.  3  and 4).  Chromosomes in the cultured cells were 
examined at the second passage. Almost every cell studied from all five tumor lines 
was  hyperploid. In each  case,  the  modal number was  tetraploid or hypotetraploid 
(range, 75-80 chromosomes). 
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TABLE  I 
PGK Phenotypes in Specimens of Normal Organs  from Pgk-ln/ Pgk-I a Mice* 
Organ  Animals  Specimens 
PGK A 
Mean  Range 
No.  No.  % 
Liver  6  33  52  40-65 
Thymus  6  25  56  35-70 
Lung  6  11  55  50-60 
Heart  6  12  50  40-65 
Intestine  5  21  50  35-60 
Muscle  6  30  53  40-80 
Kidney  4  8  51  50-60 
Blood  2  2  50  50 
* The six animals studied were Fls from crosses between feral males with Pgk- 
I a and BALB/c (two mice), AKR and NZB (one mouse each) and between 
an AKR or an NZB male crossed with F1 (feral  mice  ×  BALB/c). 
PGK (double-enzyme phenotypes) were found in each of the five tumors (Table II). 
In general, PGK phenotypes in multiple fragments from the same tumor nodule were 
similar to each other.  However, single enzyme phenotypes were observed in at least 
one fragment from a single nodule in two tumors (3 and 5). Nodule G from the tumor 
in  animal 3  showed only type A  enzyme;  two other nodules  from this same tumor 
displayed  predominantly  type  B  PGK and  tissue  culture  lines  derived  from these 
nodules showed only type B enzyme. 
PGK Phenotypes  in Clones.  The results given in Table III and Fig. 5 show that some 
of the "clones" grown  from cell cultures  derived from both tumors tested displayed 
only A-type PGK and the others showed only B-type enzyme.  Both types of clones 
were hyperploid and displayed multi-layered growth. 
Discussion 
The finding of single-enzyme PGK phenotypes in some tumor nodules and culture 
lines  confirms the  fact that  this  locus  undergoes  X-inactivation.  Consequently,  the 
occurrence of a double-enzyme phenotype in each MCA-induced tumor suggests that 
each growth contains multiple neoplastic clones. However, before this conclusion can 
be accepted it is necessary to exclude the possibilities that  the tumor samples were 
heavily contaminated with normal tissue (e.g., blood vessels) or that the tumor arose 
from a single cell in which both Pgk-1 b and Pgk-1 a were active. 
Noteworthy  contamination  with  nonneoplastic  cells  was  rendered  unlikely  by 
histologic examination'of tumor sections adjacent  to the samples assayed for PGK. 
Less than  10% of the cells were judged  to be nonneoplastic  in almost all instances. 
Furthermore, cells cultured from the tumors showed double-enzyme phenotypes and 
yet  they  exhibited  characteristics  typical  of  transformed  cells:  hyperploidy  and 
multilayered growth.  Many of these cultures had the same proportion of PGK B to 
A  isoenzyme as was observed in the tumors directly. The findings in tumors 3 and 5 
of some samples with all or mostly type B  PGK and others in the same tumor with 
predominantly or all type A  isoenzyme indicate that at least each of these neoplasms 
had more than one neoplastic clone. 
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FIG.  l.  Histopathology of section D from the fibrosarcoma induced by 0.2 mg of MCA in animal 
1.  Most cells are plump,  anaplastic, and fibroblast-like with several mitotic figures.  The section 
appears  to  contain  few  nontumor cells  except  for  some  scattered  neutrophils and  lymphocytes. 
x  252. 
Fro.  2.  Histopathology of section F from the fibrosarcoma induced by 2.0 mg of MCA in animal 
3. The section appears to contain mostly anaplastic fibroblast-like cells with several mitoses and a 
few lymphocytes and plasma cells.  X 252. 
tumors  and  cell  cultures  derived  from  them  reflect  the  phenotypes  of the neoplastic 
cells  themselves,  attempts  were  made  to  establish  clones  from  two  cultures  which 
exhibited  equal  proportions  of A-  and  B-type  PGK.  We  do  not  have  independent 
verification that  these "clones" indeed arose from single cells.  In fact, the finding that 
50%  of them  had  double-enzyme  phenotypes  suggests  that  they  arose  from  more 882  MULTICELLULAR ORIGIN OF  CHEMICALLY INDUCED TUMORS 
FIG,  3.  Phase-contrast  photomicrograph of the primary culture derived from the D portion of the 
fibrosarcoma  in animal 1. The spindle-shaped fibroblast-like  cells are randomly arranged and piled 
up.  X  1,000. 
Fio.  4.  Phase-contrast  photomicrograph of the primary culture derived from the F portion of the 
fibrosarcoma  in animal 3. The fibroblast-like  cells are spindle-shaped and piled up,  ×  600. 
than  one  cell.  Nonetheless,  the  facts  that  in  each  case some  "clones" of type A  and 
others  of  type  B  were  observed,  and  that  cells  within  these  "clones"  retained  the 
characteristics  typical  of transformed  cells  found  in  the  mass  cultures,  hyperploidy 
and  multilayered  growth,  indicate  that  the  tumor  ceil  cultures  contained  multiple 
clones  (some with PGK  type A  and  others with type B). 
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TABL~  II 
PGK Phenotypes in Normal Tissues and in MCA-induced Tumors in Feral ×  BALB/c FI Mice Heterozygous  for 
PGK 
Normal tissues  Tumors 
Animal  Percent A enzyme  MCA  Time in-  Percent A enzyme 
No.  terval*  Size  Specimen~ 
Blood  Cultured 
Muscle  Direct 
cells  cells 
mg  wk  mm 




2  50  50  0.2  21  5  ×  5  A 







4  50  40  2.0  25  29  ×  12  A 
5  50  50  2.0 
B 
C 
20  25  ×  20  A 
B 
C 
30  NO§ 
40  50 
50  45 
5O  50 
40  40 
50  20 
20  0 
80  60 
2O  0 
30  30 
50  50 
100  100 
1  40  50 
2  35  0 
3  25  ND 
4  35  ND 
1  30  50 
2  35  65 
1  30  0 
2  35  ND 
3  35  ND 
4  40  60 
1  50  50 
2  35  ND 
3  50  50 
4  35  25 
5  50  ND 
6  0  0 
1  40  0 
2  50  ND 
3  30  55 
4  35  0 
5  65  65 
6  40  50 
7  35  ND 
1  50  50 
2  50  ND 
3  50  ND 
* Time elapsed between injection of MCA and autopsy. 
:~ The tumor was first divided into sections (A-G) according to its nodular architecture. Sections 
into fragments (1-7) each measuring 3-5 mm in diameter. 
§ ND, not done. 
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TABLE III 
PGK Phenotypes in "Clones" Derived  frorn Tumor Cell Cultures 
Clones* 
Animal  Tumor  PGK phenotypes 
No.  specimen  No. studied 
A No.  B No.  A/B No. 
1  D  21  5  7  9 
3  F  20  5  5  11 
* All clones from each tumor cell culture were derived from a single flask. 
FtG. 5.  Starch gel electrophoresis of clones separated from fragment  F of the tumor from animal 
3.  Tissue  homogenates  in  slots  2  and  8  exhibit  100% A-type PGK.  Slots  1,  6,  and  9  show 
predominantly A-type PGK.  Slots 3 and  10 exhibit 100% B-type PGK. Slots 4, 5, and 7 show A- 
and B-type PGK. 
normal or neoplastic (1). However, the cells grown in culture from the MCA-induced 
tumors were hypotetraploid. We do not known the significance of this finding, but if 
the  neoplastic cells were  tetraploid or hypotetraploid before culture,  it  is probable 
that two X-chromosomes were active in each cell. Nonetheless, it is very unlikely that 
the double-enzyme phenotypes are explained by origin from single cells with both an 
active  Pgk-1 b  and  an  active  Pgk-1 a  rather  than  origin  from  multiple  cells.  This 
conclusion is supported most strongly by the findings in tumors 3 and 5. For example, 
in  tumor  3  some small samples displayed only B-type PGK  whereas others  showed 
only A-type isoenzyme, indicating the presence of at least two cell lines. A  similar cell 
composition is likely for tumors  1,  2,  and  4  even  though  all the samples from  these 
neoplasms  showed  both  B  and  A-types PGK.  The  tetraploidy in  the  cells in  these 
neoplasms (if indeed they were tetraploid before culturing) must have arisen either by 
endoreduplication (chromosome replication without cell division) or by cell fusion. A 
tetraploid cell that arises as a  result of endoreduplication presumably would have two 
active Pgk-1 b genes or two active Pgk-1 a genes (depending upon which PGK gene was 
active in the diploid cell before endoreduplication), but not one active Pgk-1 b and one 
active Pgk-1 a. Thus,  more than one endoreduplicated tumor cell progenitor for each 
tumor would be required to explain the double-enzyme phenotypes. The possibility 
that  the  tumors  arose  from  a  single  tetraploid cell  which  was  the  result  of fusion 
between two diploid cells with an active Pgk-1 b and Pgk-1 a, respectively, was rendered 
very unlikely by the demonstration of both  PGK  type A  and  type B  clones derived 
from tumors with double-enzyme phenotyes. 
Origin of each  tumor  from  more  than  one cell could come  about  in  at  least  two 
ways:  (a)  a  relatively large number of cells could be affected  (transformed)  simulta- 
neously by the carcinogen;  (b)  the  MCA  initially altered only a  single cell and  this A.  LAKSHMA REDDY AND PHILIP J.  FIALKOW  885 
alteration subsequently led to recruitment to the tumor of hitherto normal neighbor 
cells (e.g., through release, or activation, or both of an oncogenic factor). 
The results obtained in these animals with X-linked mosaicism contrast with those 
obtained by Iannaccone et al. (6) in chimeric mice made by the amalgamation of two 
embryos, each  producing  a  different  electrophoretic  variant of the  enzyme glucose 
phosphate isomerase. The smallest samples of normal tissues that could be analyzed 
almost  invariably contained  both  isoenzymes, but  almost  all  chemical  carcinogen- 
induced  tumors had  single-enzyme phenotypes.  Those workers concluded  that  the 
epidermal tumors produced could not have arisen from more than eight cells and in 
all likelihood were clonal in origin. There are several possibilities to explain our failure 
to observe similar results.  First, we studied  fibrosarcomas, whereas Iannaccone et al. 
(6)  studied  predominantly epidermal tumors. Second, in our experiments the MCA 
was completely dissolved in the solvent. Third, we used X-linked mosaic mice, whereas 
Iannaccone et al. (6) used chimeras. The patch size is probably larger in chimeras (7, 
8);  consequently,  the probability that a  tumor with multicellular origin will have a 
single-enzyme phenotype is greater. 
Because MCA-induced tumors have unique tumor specific transplantation antigens 
(9),  it  had  been  assumed  by  some  that  all  such  neoplasms  are  clonal  in  origin. 
However, Prehn and co-workers (10) sampled opposite poles of nine tumors and found 
evidence for at least two tumor-specific transplantation  antigens in one neoplasm. If 
more extensive sampling had been done, it is conceivable that similar findings would 
have been  made in  other  tumors.  Another possibility is  that  the Fls  between  these 
feral  mice and  BALB/c  are  particularly  susceptible  to  tumor transforming events. 
Thus,  such  animals  may have tumors of multicellular  origin  in  contrast  to  inbred 
strains of mice with MCA-induced tumors. 
These  results  also  suggest  an  explanation  for  the  difference  in  immunogenicity 
noted between spontaneously occurring tumors and chemically induced  neoplasms. 
The  former  are  not  at  all  or  only  weakly  immunogenic  (11,  12,  13),  whereas 
chemically-induced  tumors  are  highly  immunogenic  (14,  15). Furthermore,  immu- 
nogenicity increases with  increasing carcinogen doses even if the latency period for 
tumor development does not change (t5). It is possible that tumors induced with high 
doses of carcinogen are strongly immunogenic because they are multicellular in origin 
and, therefore, have diverse tumor-associated transplantation  antigens. On the other 
hand, spontaneously occurring neoplasms or those induced by low doses of carcinogen 
are more likely to be clonal in origin, have only one type of tumor-associated antigen 
and, therefore, be weakly immunogenic. Recently it was reported that immunogenicity 
of AKR leukemia cells is markedly augmented if several clones, each with a distinct 
antigen(s), are used as the immunogen (16). 
Although every MCA-induced neoplasm we studied contained multiple neoplastic 
clones, we do not  know if the neoplasms had a  multicellular origin or if there were 
multiple  primaries which  fused  to simulate  one  tumor.  Perhaps  this  distinction  is 
essentially semantic.  In either event, the results suggest  that at  the doses and in the 
animals we used the tumorigenic event induced  by MCA may not be as rare as had 
been previously supposed.  A  critical  question  will  be to determine whether  tumors 
induced  with  low doses of MCA under circumstances more likely to simulate spon- 
taneous neoplasms in  man, will  have clonal origin.  And finally, the results of these 
experiments  indicate  that  it  should  not  be assumed  in  investigations  using  MCA- 
induced tumors that the neoplasms necessarily have a clonal origin. 886  MULTICELLULAR ORIGIN OF CHEMICALLY INDUCED TUMORS 
Summary 
The cellular origin  of tumors  induced  by the chemical  carcinogen 3-methylchol- 
anthrene  (MCA)  was  studied  in  mice with  X-chromosome inactivation  mosaicism. 
Because only one of the two X-chromosomes is active in XX somatic cells, a  female 
heterozygous at  the X-linked  phosphoglyeerate  kinase  (PGK-1)  locus  for the  usual 
Pgk-1 b gene and  the  variant  Pgk-1 a has  two populations  of cells,  in  the cells of one 
population, Pgk-1 b is active and B-type enzyme is synthesized, whereas in cells of the 
other population, A-type enzyme is produced. Both enzyme types are found in normal 
tissues  from these mosaic mice.  A  tumor developing from a  single cell exhibits  only 
one  of the  two  PGK  enzyme  types,  whereas  a  tumor  with  a  multicellular  origin 
expresses both enzymes (i.e.,  it has a  double-enzyme phenotype). 
Five fibrosarcomas developing at the site of injection of 0.2 or 2.0 mg of MCA were 
analyzed.  36 of 38 fragments from the five tumors had double-enzyme PGK pheno- 
types.  One  piece  from  each  of  two  tumors  showed  a  single-enzyme  phenotype. 
Histological,  cell culture,  and cloning studies  indicate  that  the double-enzyme phe- 
notypes reflect  the  presence  of both  types of malignant  cells  and  not  admixture  of 
normal with neoplastic elements in the specimens tested for PGK. The results suggest 
strongly that these fibrosarcomas have a  multicellular  origin. 
We thank Alec Constabaris,  Wendy Fisher,  Melody James,  and  Laura Steinmann  for their 
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Received  for publication l l June 1979. 
References 
1.  Fialkow, P. J.  1976. Clonal origin of human tumors. Biochim. Biophys. Acta. 458:283. 
2.  Nielsen,  J. T., and V. W. Chapman.  1977. Electrophoretic variation for X-chromosome- 
linked phosphoglycerate kinase (PGK-1) in the mouse. Genetics. 87:319. 
3.  Chen, S. H., L. A. Malcom, A. Yoshida, and E. R. Giblett.  1971. Phosphoglycerate kinase: 
an X-linked polymorphism in man. Am. J. Hum. Genet. 23:87. 
4.  Beutler, E.  1969. Electrophoresis of phosphoglycerate kinase.  Biochem. Genet. 3:189. 
5.  Fialkow, P.J.  1972. Evidence for a clonal origin of head and neck tumors. Int. J.  Cancer. 9: 
133. 
6.  Iannaccone, P. M., R. L. Gardner, and H. Harris.  1978. The cellular origin of chemically 
induced tumors. J.  Cell Sci. 29:249. 
7.  McLaren, A. 1976. Mammalian Chimaeras. Cambridge University Press,  London. 
8.  Falconer, D. S., and P. J. Avery. 1978. Variability of chimaeras and mosaics, or. Embryol. 
Exp. Morph. 43:195. 
9.  Prehn, R. T.  1970. Analysis of antigenic heterogeneity within individual 3-methylcholan- 
threne-induced mouse sarcomas. J. Natl. Cancer Inst. 45:1039. 
10.  Prehn, R. T.  1965. Cancer antigens in tumors induced by chemicals. Fed. Proc. 24:1018. 
11.  Prehn, R. T., and J. M. Main.  1957. Immunity to methyleholanthrene-induced sarcomas. 
J. Natl. Cancer Inst. 18:769. 
12.  Baldwin,  R.  W., C.  R.  Barker,  and  M. J.  Embleton.  1968. Immunology of carcinogen- 
induced  and  spontaneous  rat  tumors.  In  Advances  in  Transplantation.  J.  Dausset,  F. 
Humburger, and C. Mathe, editors. The Williams & Wilkins Co., Baltimore. 503. 
13.  Hewitt,  H. G., E. R. Blake,  and A. S. Walder.  1976. A critique of the evidence for active 
host defense against cancer, based on personal studies of 27 murine tumors of spontaneous 
origin. Brit. J.  Cancer. 33:241. A.  LAKSHMA REDDY AND  PHILIP J.  FIALKOW  887 
14.  Baldwin, R. W. 1973. Immunological  aspects of chemical carcinogenesis. Adv. Canc. Res. 18: 
i. 
15.  Prehn, R. T. 1975. Relationship of tumor immunogenicity  to concentration of the oncogen. 
J. Natl.  Canc. Inst, 55:189. 
16.  Olsson, L.,  and P.  Ebbesen.  1979. Natural polyclonality of spontaneous AKR leukemia 
and its consequences for so-called immunotherapy.  J. Natl.  Cancer Inst. 62:623. 